UK Health Economics

Published
September 21, 2026

UK Health Economics

icon-benefit
Pending Trial Data
HomeSNAP Proposals
UK Health Economics

SNAP UK Health Economics

  • A detailed health economics evaluation to inform UK policy and future guidelines

The study aims to:

  • Examine the cost-effectiveness according to the NICE (UK National Institute of Clinical Effectiveness) reference case of interventions in SNAP in a UK setting
  • Determine the cost per episode of SAB in the UK
  • Explore long-term impacts of SAB in the UK.
Lead Investigator Contact Details

For any questions about this analysis, please reach out using the contact details below:

Name: Prof. Anna Goodman

Institute: University College London Innovative Clinical Trials Unit

Email: anna.goodman@nhs.net

SNAP Proposals

View All Proposals

C-SNAP

Evaluating the prevalence of vitamin C deficiency and plasma vitamin C level decay in a prospective sample of patients with Staphylococcus aureus bacteraemia enrolled in the SNAP trial

icon-benefit
New Zealand
icon-benefit
Substudy in Progress

PWID

People Who Inject Drugs Substudy

icon-benefit
All
icon-benefit
Substudy in Progress

CERT-SNAP

Combination Cefazolin with Ertapenem for methicillin-susceptible Staphylococcus aureus bacteremia.

icon-benefit
Canada
icon-benefit
Substudy in Progress

Cell-free DNA

A Versatile Analyte to Monitor Complications and Guide Treatment Duration in Staphylococcus aureus Bacteremia

icon-benefit
Canada
icon-benefit
Substudy in Progress

SNAP-strat

SNAPstrat: Patient stratification using SAB sub-phenotypes

icon-benefit
Any Interested
icon-benefit
Substudy in Progress

SNOOPY

Staphylococcus aureus Network: ultrasound for diagnosis of endovascular disease in Paediatrics and Youth

icon-benefit
Australia
icon-benefit
Substudy in Progress